- Clinical Development
- Therapeutic Expertise
- News & Resources
High quality and accurate data analysis is an important component of all clinical trials. Typically, it is thought by sponsors to occur at the end of a study when the CRO starts reporting results to sponsors and investors. However, Biostats can and should also function as an aspect that has value at the outset of the study and at multiple points throughout the clinical development process.
Experience matters. SynteractHCR was founded as a Biostats provider and has more than two decades of experience in this area. This longstanding Biostats expertise is now being offered to our clients in three different options depending on your needs:
Working as your partner, SynteractHCR’s expert biostatisticians and consulting group will review your study’s needs and determine the best methods for collecting, analyzing and presenting your data, all in compliance with regulatory guidelines. Our long-tenured team provides creative thinking and analysis optimized for your unique
You may choose any or all of these processes as part of your full-service, consulting or standalone Biostatistics options:
Since its inception, SynteractHCR has contributed to marketing applications and regulatory submissions. Our processes and experience have evolved and adapted quickly with the rapidly changing regulation landscape. We provide access to your data in a format well-suited to your project requirements (21 CFR Part 11, eCTD, CDISC) and that meets regulatory standards.
SynteractHCR is able to provide “out of the box” thinking and analysis that will improve your clinical study design and biostats output with a responsiveness that is unmatched in the industry. Work with SynteractHCR to ensure the best statistical services for your trials.
Our goal is to provide
you with the services
that best meet your
needs. Talk to
us - we’ll help you